You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

afatinib

Showing 26 - 50 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Squamous Cell of Head and Neck Trial in France (Afatinib)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Afatinib
  • Angers, France
  • +10 more
Feb 1, 2022

NSCLC Stage IV Trial in Taipei (therapeutic thoracic surgery, Afatinib)

Recruiting
  • NSCLC Stage IV
  • therapeutic thoracic surgery
  • Afatinib
  • Taipei, Taiwan
  • +1 more
Mar 8, 2022

Gallbladder Carcinoma Trial in Shanghai (gemcitabine and oxaliplatin., Afatinib)

Recruiting
  • Gallbladder Carcinoma
  • gemcitabine and oxaliplatin.
  • Afatinib
  • Shanghai, Shanghai, China
  • +1 more
Dec 21, 2022

Rare Tumor, Refractory Tumor Trial in Shanghai (Gefitinib, Erlotinib, Afatinib)

Recruiting
  • Rare Tumor
  • Refractory Tumor
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Feb 16, 2022

HER2/Neu+ Uterine Serous Carcinoma Trial in Tucson, New Haven, Boston (Afatinib)

Recruiting
  • HER2/Neu+ Uterine Serous Carcinoma
  • Afatinib
  • Tucson, Arizona
  • +2 more
Feb 2, 2022

NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Avitinib Maleate
  • +13 more
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 3, 2022

Afatinib Osimertinib Sequencing NIS

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Vienna, Austria
    Otto-Wagner Hospital
Dec 23, 2020

Squamous Cell Carcinoma of the Head and Neck Trial in Boston, New York (Afatinib, Docetaxel, Radiation Therapy)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Afatinib
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 25, 2021

Head and Neck Squamous Cell Carcinoma Trial in France (AFATINIB, Placebo of AFATINIB)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • AFATINIB
  • Placebo of AFATINIB
  • Angers, France
  • +25 more
May 28, 2021

Epidermal Growth Factor Receptor Mutations in Advanced EGFR

Completed
  • Non Small Cell Lung Cancer
  • +2 more
  • Afatinib
  • (no location specified)
Dec 22, 2020

NSCLC Trial in Worldwide (Afatinib, pembrolizumab)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Lexington, Kentucky
  • +12 more
Feb 5, 2021

Non-small Cell Lung Carcinoma, Urothelial Carcinoma, Gastrointestinal Carcinoma, Non-colon Trial in United States (afatinib,

Completed
  • Non-small Cell Lung Carcinoma
  • +3 more
  • afatinib
  • +2 more
  • Denver, Colorado
  • +7 more
Aug 17, 2022

Lung Cancer, Breast Cancer, Brain Cancer Trial in United Kingdom (Afatinib, 2 Gy targeted radiotherapy, 4 Gy targeted

Unknown status
  • Lung Cancer
  • +4 more
  • Afatinib
  • +2 more
  • Cambridge, England, United Kingdom
  • +5 more
Jan 12, 2021

Lung Cancer Trial in Boston (drug, radiation, procedure)

Unknown status
  • Lung Cancer
  • Afatinib
  • +4 more
  • Boston, Massachusetts
  • +1 more
Jul 1, 2020

Neuroectodermal Tumors, Rhabdomyosarcoma Trial in Worldwide (afatinib)

Completed
Has Results
  • Neuroectodermal Tumors
  • Rhabdomyosarcoma
  • afatinib
  • Boston, Massachusetts
  • +27 more
Mar 3, 2021

Non Small Cell Lung Cancer Trial in Palo Alto, Boston, New York (Afatinib)

Unknown status
  • Non Small Cell Lung Cancer
  • Afatinib
  • Palo Alto, California
  • +3 more
Jul 1, 2020

NSCLC Trial in Worldwide (afatinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • afatinib
  • Randwick, New South Wales, Australia
  • +117 more
Aug 23, 2022

Urologic Tumors Trial in France, Italy, Spain (Afatinib)

Completed
Has Results
  • Urologic Neoplasms
  • Afatinib
  • Bordeaux, France
  • +29 more
Oct 28, 2020

Squamous Cell Carcinoma Trial in Singapore (Afatinib)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Afatinib
  • Singapore, Singapore
    National University Hospital
Aug 26, 2020

HER2-positive Breast Cancer, Brain Metastases Trial in China (Afatinib, T-DM1)

Recruiting
  • HER2-positive Breast Cancer
  • Brain Metastases
  • Beijing, Beijing, China
  • +3 more
May 9, 2020

Bevacizumab Plus EGFR-TKIs in Chinese EGFR-mutant

Recruiting
  • NSCLC
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Oct 17, 2020

Advanced NSCLC With EGFR-mutations

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Afatinib
  • Multiple Locations, Germany
    (unnamed)
Dec 19, 2019

NSCLC, ErbB Receptors Trial in United States (Afatinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • ErbB Receptors
  • Afatinib
  • Scottsdale, Arizona
  • +9 more
Mar 16, 2020

Lung Squamous Cell Carcinoma Trial in Shanghai (Afatinib)

Unknown status
  • Lung Squamous Cell Carcinoma
  • Afatinib
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Oct 25, 2019

NSCLC Trial in China, Malaysia (afatinib, paclitaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Changsha, China
  • +8 more
Sep 6, 2019